LITHIA, Fla. — It has been 15 years since U.S. Army Sgt. Nicole Leger deployed to Afghanistan. Named in honor of Sgt. First Class Heath Robinson, a decorated combat medic who died from a rare form of ...

Teva Pharmaceuticals (TEVA) secures exclusive global rights to a biosimilar candidate targeting Roche’s (RHHBY) multiple ...

Andy Burnham's decision to stick with Rachel Reeves's fiscal rules and moderate some of his more radical policies have led ...

The State Courts are partnering community organisations to expand rehabilitation efforts for offenders even before sentencing ...

Glazed in sweat and surrounded by swirls of steam, Tyler Hart and Bill Robertson made an informal pact that would eventually ...

Genentech is continuing its summer of downsizing and cost-cutting, this time with plans to terminate a cell therapy deal worth as much as $2 billion. The pact is with Adaptive Biotechnologies and ...

On June 12, 2026, the European Union Migration and Asylum Pact will become fully applicable. The Pact is a set of 10 pieces of binding legislation, adopted in 2024, that overhauls how the EU manages ...

Co-legislators agreed on “return hubs” on 1 June, preparing to rollout the Migration and Asylum Pact of 12 June. Stricter border controls, uniform asylum rules, and a new digital monitoring system ...

Chief Financial Officer Mark Voll stated, we do not see any real increase in operating expenses as we move forward. but also disclosed that Q1 selling, general, and administrative expense was above ...

Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality. Following its exit from the cell ...

NEW YORK – Gilead Sciences' Kite Pharma has inked a $1.64 billion in vivo cell therapy deal with Pregene Biopharma, the Chinese biotech announced Thursday. Kite has paid $120 million upfront to ...